Expert Perspectives
Program director Dr. Lindsey Gurin highlights the double-board residency program’s unique value and approach to training.
Dr. Joshua Siegel, an expert on the psychedelic, discusses how its rapid, dramatic, and lengthy effects could make it a potent antidepressant.
Advancing Science
A new study sheds light on the factors that drive—or discourage—patient engagement.
Dr. Carla Nasca on how a mitochondrial metabolite could yield a new disease biomarker and precision medicine strategy.
In Conversation With
The department chair discusses the current mental health awakening, his research on PTSD, and the future of psychiatry treatment.
A recent fMRI study is the first to map neural networks affected by psilocybin in alcohol use disorder.
Vote Now
